Latest filing published 01 Mar 2013 for Marinemax INC, €6,859.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -50.3%Entry US$14.56 · Close at T+365 US$7.23
- -5.1%Entry US$20.88 · Close at T+365 US$19.81
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert S. Kant: trading record in brief
Robert S. Kant is a declared insider of Marinemax Inc, with filings sourced from SEC (Form 4). The record holds 52 filings, for trades running from 30 December 2005 to 28 February 2013.
In open-market terms, that means 2 purchases worth €74k on one side and 20 sales worth €128k on the other. Sales outweigh purchases by €54k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 29 share grants and 1 option exercise. Since January 2013: no purchases and 8 sales on the market.
The newest entry dates from 1 March 2013: an option exercise of €6,859, in Marinemax Inc. The clock since the last published purchase (30 August 2007) now reads 7,010 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert S. Kant
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000 shares@ US$9.02Common StockSEC:0001209191-13-012935:0
- 199 shares@ US$12.84Common StockSEC:0001209191-13-012935:1
- 100 shares@ US$12.88Common StockSEC:0001209191-13-012935:2
- 200 shares@ US$12.89Common StockSEC:0001209191-13-012935:3
- 100 shares@ US$12.90Common StockSEC:0001209191-13-012935:4
- 100 shares@ US$12.91Common StockSEC:0001209191-13-012935:5
- 100 shares@ US$12.92Common StockSEC:0001209191-13-012935:6
- 101 shares@ US$12.93Common StockSEC:0001209191-13-012935:7
- 100 shares@ US$12.94Common StockSEC:0001209191-13-012935:8
- 1,118 sharesCommon StockSEC:0001209191-13-001094:0
- 1,207 sharesCommon StockSEC:0001209191-12-047633:0
- 1,051 sharesCommon StockSEC:0001209191-12-036429:0
- 100 shares@ US$10.84Common StockSEC:0001209191-12-025307:5
- 600 shares@ US$10.85Common StockSEC:0001209191-12-025307:6
- 200 shares@ US$10.86Common StockSEC:0001209191-12-025307:7
- 1,600 shares@ US$11.00Common StockSEC:0001209191-12-025307:8
- 300 shares@ US$11.02Common StockSEC:0001209191-12-025307:9
- 200 shares@ US$10.78Common StockSEC:0001209191-12-025307:0
- 100 shares@ US$10.79Common StockSEC:0001209191-12-025307:1
- 400 shares@ US$10.81Common StockSEC:0001209191-12-025307:2
- 100 shares@ US$10.82Common StockSEC:0001209191-12-025307:3
- 1,400 shares@ US$10.83Common StockSEC:0001209191-12-025307:4
- 5,000 shares@ US$11.03Common StockSEC:0001209191-12-025307:10
- 1,215 sharesCommon StockSEC:0001209191-12-020806:0
- 1,534 sharesCommon StockSEC:0001209191-12-001012:0
25 of 52 declarations